Compared with non-Hispanic White (NHW) children, non-Hispanic Black (NHB) and Hispanic/Latino (HL) children with a headache diagnosis in the emergency department have lower rates of migraine diagnosis ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Occupational exposure to noise and/or vibrations is associated with the presence of vertigo, according to a study.

Older adults who engage in daily nut consumption have a significantly lower risk for death, dementia, and physical disability.

Children of women with epilepsy prescribed antiseizure medications do not have significant neurodevelopmental differences at age 6 years.

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.

Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.

Social determinants of health, such as Area Deprivation Index scores, may be considered mild cognitive impairment risk factors among older adults.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Exposure to traffic-related air pollution (TRAP) is associated with depression in women, possibly via reproductive health.